No Picture
Kalytera Therapeutics Inc.

Kalytera Announces Next Payment in Shares under Services Agreement with Salzman Group

SAN FRANCISCO and TEL AVIV, Israel, April 20, 2018 (GLOBE NEWSWIRE) — Kalytera Therapeutics, Inc. (TSX VENTURE:KALY) (OTCQB:KALTF) (the “Company” or “Kalytera“) today announced that the Company has elected to issue 772,346 common shares of […]

No Picture
Kalytera Therapeutics Inc.

Kalytera Announces Issuance of Patent Covering the Use of CBD for the Treatment of Severe and Refractory Graft Versus Host Disease

SAN FRANCISCO & TEL AVIV, Israel Kalytera Therapeutics, Inc. (TSX VENTURE: KALY and OTCQB: KALTF) (the “Company” or “Kalytera“) today announced that the U.S. Patent and Trademark Office (“USPTO“) issued U.S. Patent No. 9,889,100 B2 […]

No Picture
Kalytera Therapeutics Inc.

Kalytera Announces Next Issuance of Shares under Services Agreement with Salzman Group

SAN FRANCISCO and TEL AVIV, Israel, March 22, 2018 (GLOBE NEWSWIRE) — Kalytera Therapeutics, Inc. (TSX VENTURE:KALY) (OTCQB:KALTF) (the “Company” or “Kalytera“) today announced that the Company has elected to issue 444,943 common shares of […]

No Picture
Kalytera Therapeutics Inc.

Kalytera Initiates Program to Develop a Novel Cannabinoid-Based Compound for Treatment of Acute and Chronic Pain

Kalytera Therapeutics, Inc. (TSX VENTURE: KALY and OTCQB: KALTF) (the “Company” or “Kalytera“) today announced that it has begun development of a novel cannabinoid-based compound for the treatment of acute and chronic pain. Patents for […]

No Picture
Kalytera Therapeutics Inc.

Kalytera Announces Grant of Stock Options to Chief Scientific Officer and Chief Medical Officer

SAN FRANCISCO and TEL AVIV, Israel, March 14, 2018 (GLOBE NEWSWIRE) — Kalytera Therapeutics, Inc. (TSX VENTURE:KALY) (OTCQB:KALTF) (the “Company” or “Kalytera“) today announced that it has granted stock options on March 13, 2018 to […]

No Picture
Kalytera Therapeutics Inc.

Kalytera Announces Issuance of Shares under Services Agreement with The Salzman Group of Israel

SAN FRANCISCO and TEL AVIV, Israel, Jan. 26, 2018 (GLOBE NEWSWIRE) — Kalytera Therapeutics, Inc. (TSX-V:KALY) (OTCQB:KALTF) (the “Company” or “Kalytera“) today announced that the Company has elected to issue 396,015 common shares of the […]